Walsh Medical Media (WMM) presents peer-reviewed original research and analysis that deals exclusively with the treatment of schizophrenia and related psychoses and is directly relevant to patient care through:
Unique, disease-specific focus - WMM is the only clinical publication dedicated entirely to the latest research and advances in the diagnosis and treatment of schizophrenia and related psychoses.
Clinically-driven content - Each quarterly issue provides practice-oriented original research results, case reports, comprehensive reviews, current treatment protocols, drug therapy updates, and clinical trial news, as well as meeting highlights from major conferences.
Peer-reviewed credibility - Our distinguished Editorial Board is comprised of prominent schizophrenia researchers and clinicians from around the world.
Exceptional 20/80 ad-to-edit ratio - Delivers maximum editorial coverage for our readers and maximum exposure for our select sponsors.